Muralikrishna Golconda, M.D., M.R.C.P.
|
Philosophy of CareMy goal as a physician caring for a complex group of patients is to emphasize the importance of a team approach in achieving the best possible outcomes in transplant recipients. I consider the patient's community physicians as a vital part of this team. I enjoy bedside teaching and the challenges of clinical research, and integrate these with my clinical care focus in delivering high-quality medical care. |
Title: |
Associate Professor |
Specialty: |
Nephrology |
Center/Program Affiliation: |
Transplant Center |
Address: |
UC Davis Medical Center - Cypress Building 2221 Stockton Blvd. Sacramento, CA 95817 |
Phone: |
(916) 734-8491 |
Other Languages: |
Hindi, Tamil, Telugu |
Education: |
Royal College of Physicians United Kingdom United Kingdom M.R.C.P. 1988 Kilpauk Medical College Madras India M.D. 1985 |
|
D.G. Vaishnav College Chennai, India India 1975 |
|
Residency: |
Mayo Clinic Rochester, MN 1993-1995 Nephrology Royal College of Physicians of the United Kingdom accredited hospitals United Kingdom 1986-1988 Internal Medicine Kilpauk Medical College Chennai India 1982-1985 Internal Medicine |
Fellowships: |
Oregon Health & Science University Portland, OR 1995-1996 Nephrology University of Arkansas for Medical Sciences AR 1992-1993 Nephrology Toronto General & Western Hospitals Toronto Canada 1990-1992 Nephrology Stobhill General Hospital Glasgow United Kingdom 1988-1990 Nephrology |
Board Certifications: |
American Board of Internal Medicine, Nephrology, 1997 American Board of Internal Medicine, 1995 |
Professional Memberships: |
American Society of Nephrology American Society of Transplantation Association of Physicians of India Royal College of Physicians of the United Kingdom |
Select Recent Publications: |
Barry JM. Conlin M. Golconda M. Norman D. Strategies to increase living donor kidney transplants. Urology 2005; 66(5 Suppl): 43-6 Keith D.S. DeMattos A. Golconda M. Prather J. Cantarovich M. Paraskevas S. Tchervenkov J. Norman DJ. Factors associated with improvement in deceased donor renal allograft function in the 1990s. J. Am. Soc. Nephrol 2005; 16(5): 1512-21. de Mattos, A.M., Olyaei, A.J., Prather, J.C., Golconda, M.S., Barry, J.M., Norman, D.J. Autosomal Dominant Polycystic Kidney Disease as a risk factor for Diabetes Mellitus following renal transplantation. Kidney International 2005; 67(2): 714-20. Keith, D.S., de Mattos, A.M., Golconda, M., Prather, J., Norman, D. Effect of donor recipient age match on survival after first deceased donor renal transplantation. J. Am. Soc. Nephrol 2004; 15(4): 1086-91. Whiting, J.F., Golconda, M., Hayes, R., Smith, R., O'Brien, S., First, M.R., Alexander, J.W. Economic costs of Expanded Criteria Donors in Renal Transplantation. Transplantation 1998; 65(2): 204-7. Golconda, M.S., Larson, T.S., Kolb, L., Kumar, R. 1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient. Mayo Clinic Proceedings 1996; 71(1): 32-36. Golconda, Muralikrishna. S., Ueda, N., Shah, S.V. Evidence suggesting that iron and calcium are interrelated in oxidant-induced DNA damage. Kidney International 1993; 44: 1228-1234. Czapla K., Rodger, R.S., Halls, D.J., Muralikrishna, G.S., Macdougall, A.I., Fell, G.S. Ranitidine reduces aluminium toxicity in patients with renal failure. Nephrol Dial Transplant 1992; 7(12): 1246 - 8. Rodger, R.S., Muralikrishna, G.S., Halls, D.J., Henderson, J.B., Forrest, J.A., Macdougall, A.I., Fell, G.S. Ranitidine suppresses aluminium absorption in man. Clinical Science 1991; 80(5): 505-508. Muralikrishna, G.S., Rodger, R.S., Macdougall, A.I., Boulton-Jones, J.M., Allison, M.E., Kyle, K.F., Junor, B.J., Briggs, J.D. Renal replacement therapy in patients with spina bifida or spinal cord injury. Br. Med. J 1989; 299(6714): 1506. |

